Invention Grant
- Patent Title: Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
-
Application No.: US16463364Application Date: 2017-12-01
-
Publication No.: US11806392B2Publication Date: 2023-11-07
- Inventor: David E. Briles , Hiroshi Kiyono , Robert Kneller , Reshmi Mukerji , Kristopher Genschmer , Yoshikazu Yuki
- Applicant: The UAB Research Foundation , The University of Tokyo
- Applicant Address: US AL Birmingham
- Assignee: The UAB Research Foundation,The University of Tokyo
- Current Assignee: The UAB Research Foundation,The University of Tokyo
- Current Assignee Address: US AL Birmingham; JP Tokyo
- Agent Wiley Rein
- International Application: PCT/US2017/064347 2017.12.01
- International Announcement: WO2018/102774A 2018.06.07
- Date entered country: 2019-05-22
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61P31/04 ; C07K14/315 ; A61K39/00

Abstract:
The present embodiments provide compositions and methods related to novel recombinant protein immunogens, comprising specific portions of alpha helical domains (aHD) and proline rich regions (PRD) of pneumococcal surface protein A (PspA), which portions are linked to provide aHD-PRD constructs. The aHD and PRD proteins constituting the aHD-PRD constructs are selected to maximize cross-reactivity and provide protection against a broad spectrum of pneumococcal serotypes. Immunogenic compositions, including vaccines, comprising at least one aHD PRD construct may also include a non-linked aHD portion. Also provided are recombinant nucleic acid molecules that encode aHD-PRD constructs, vectors and recombinant host cells containing such molecules, aHD-PRD expression products, use of such nucleic acid molecules to express aHD-PRD constructs by recombinant techniques, and use of the expression products to elicit an immune or protective response against pneumococcal disease in a suitable host.
Public/Granted literature
Information query